About Our Funding Programs
MaRS Innovation can only accept technology emerging within or connected to our members.
As such, our funding programs are only open to researchers, students, or other affiliated staff within our membership. If you’re unsure if you’re eligible, contact the technology transfer office at your institution.
Individual programs may have other acceptance criteria as described below.
Medical Sciences Proof-of-Principle (MSc PoP) program
The Medical Sciences Proof-of-Principle (MSc PoP) program, administered by Ontario Centres of Excellence on behalf of Ontario’s Ministry of Research & Innovation, is a province-wide initiative for which MaRS Innovation accepts applications from our 15 member institutions.
We are currently accepting proposals for the January 2016 funding round (deadline has been extended to March 4, 2016).
There will be a second MSc PoP call in September 2016.
MSc PoP Program Criteria
All MSc PoP programs use the same criteria. Here’s how to apply from within the MaRS Innovation member community:
- Applicants and/or start-ups can apply for up to $70,000 per project.
- New industry matching cash contributions are required for a combined total maximum funding of $140,000.
- Detailed guidelines for the MSc PoP program are posted on OCE’s website, where you can also download the proposal questions.
- Applications from MI member institutions are submitted through Jackie Terry, the PoP program administrator, by 2 pm on March 4, 2016.
After being pre-screened by an external review panel, MaRS Innovation will formally submit applications on behalf of our member institutions and their start-up companies through OCE’s online application system.
Selected applicants will be invited for in-person presentations to the External Review Panel who will make a recommendation to the OCE Internal Review Panel for funding decisions.
Researchers within MaRS Innovation members should direct any questions about the PoP process should be directed to Jackie Terry.
Applicants must download and complete the following documents:
- OCE 2016 Funding call: MI MScPoP Procedure for Applicants: This document contains a step-wise procedure to gather all of the application information.
- MScPoP Info Required to Initiate Projects — Information provided in Step 1 in blue in the Procedure document can be input here and must be sent by MI to OCE to initiate an application. Please provide this information when you have it, regardless of whether your application is ready, so that OCE may assign you a unique number that will allow them to access the full online application.
- Schedule D Template — The Intellectual Property Term Sheet will be included in a funding agreement if the application is successful; OCE requires the schedule as an attachment with the application.
- MScPoP Eligible Expenses — These expenses are eligible for reimbursement through the MSc PoP program.
The University of Toronto’s Early-Stage Technology (UTEST) Program is part of U of T’s growing ecosystem of incubators and commercialization support services.
UTEST accepts companies in the very earliest stages of idea generation— before they’re ready for traditional incubators. To date, three cohorts have completed the program (16 companies in total) and a fourth is currently incubating.
UTEST companies receive start-up funding, mentoring, business strategy and office space in the MaRS Discovery District facility, along with $30,000 in start-up funds.
Funding for the companies come from MaRS Innovation and U of T’s Connaught Fund.
UTEST has been selected as of one of seven true start-up accelerators in Canada by a 2013 MaRS Catalyst report. Betakit also profiled UTEST among eight other Canadian top accelerators and incubators, and BlogTO ranked it among Toronto’s Top 10 accelerators.
Past graduates include Granata Decision Systems, Whirlscape, Crowdmark, TrendMD, eQOL, Nvest and Onyx Motion.
MaRS Innovation jointly administers UTEST in partnership with the U of T’s Innovations & Partnerships Office.
To learn more about UTEST, contact:
MaRS Innovation Industry Access Program
The MaRS Innovation Industry Access Program (MI-IAP) was created to help researchers securing funding for early-stage technologies through MI’s collaborative R&D programs with strategic industry partners.
The program’s three key benefits are:
- Gauging commercial interest in new technologies.
- Presenting technologies to industry partners who may participate in future grant programs that require an industry match.
- Potential to access committed funding through MI’s co-managed strategic partnership funds with five large pharmaceutical companies (Baxter, GSK, Johnson & Johnson, Merck and Pfizer) and one diagnostics company (LifeLabs, which was formerly CML Healthcare). These funds are accessible to MI-managed technologies on a continual basis, but applicants to the MI-IAP are also eligible to access the funds, should the industry partner select the project for further diligence and elect to use the committed funds.
The program, which runs three times per year, is open to any researcher affiliated with our 15 members who has developed therapeutic, diagnostic, medical device or health IT related technologies in the following areas (note that areas of interest may change each round):
- Orphan indications
- Respiratory system diseases (e.g., Chronic obstructive pulmonary disease (COPD), asthma, lung cancer, etc.)
- General surgery
Recommended budgets range from $75,000 to $150,000.
Applications are currently closed.
MaRS Innovation internally reviews all submitted statements. If MI sees a prospective match between a strategic partner’s expressed interest and a researcher’s statement, the researcher will be invited to complete the non-confidential application summary, which includes:
- MI-IAP 2015Q1 B Non-Confidential Summary Slide
- MI-IAP 2015Q1 C Non-Confidential Technology Summary
- MI-IAP 2015Q1 D Project Budget
Since the MI-IAP is a partnership development program, funding is not guaranteed; the application materials are deliberately brief. Statements of interest are to be one paragraph in length and do not guarantee funding; they are considered by MaRS Innovation for internal reviews only.
MI also reserves the right to review all submitted statements for prospective matches between technologies and the interests expressed by MI’s strategic partners.
If there is alignment between a partner’s criteria and an application, MI will invite the selected researchers to prepare a non-confidential summary of the technology, which includes:
- A three-page (maximum) non-confidential technology summary (see MI-IAP 2015Q1 C Non-Confidential Technology Summary)
- A single PowerPoint slide (see MI-IAP 2015Q1 B Non-Confidential Summary Slide)
- A project budget (see MI-IAP 2015Q1 D Project Budget)
- Funding is not guaranteed at any point in this process. The program’s success indicator is an invitation by at least one partner to present the technology in more detail, which may or may not lead to funding.
- If a researcher’s non-confidential summary attracts interest from a strategic partner, MI will arrange a meeting or conference call with the partner to initiate their due diligence.
- Upon completion of their investigation, the partner, at its exclusive option, may decide to deploy funding for the project.
- All successful projects are subject to the terms of the member agreement between MI and its members.
- Projects encumbered by a third party are not eligible for this program.
Technology Transfer and Scouting Department
Five of MaRS Innovation’s members have small technology transfer offices or no dedicated staff.
For these members, MI staff provide or augment their technology transfer services:
- Holland Bloorview Kids Rehabilitation Hospital
- Sunnybrook Health Sciences Centre
- St. Michael’s Hospital
- Women’s College Hospital
- York University
If you have questions about the Technology Transfer and Scouting program, contact Ben Rogers.